Toll-like receptor 9 SNPs are susceptible to the development and progression of membranous glomerulonephritis: 27 years follow-up in Taiwan

Renal Failure

Volumn 35, Issue 10, 2013, Pages 1370-1375

  Chen, Yng Tay ^a   Wei, Chang Ching ^a   Ng, Ka Lok ^b   Chen, Cheng Hsu ^c   Chan, Chia Jung ^a   Chen, Xian Xiu ^a   Chang, Yuan Yen ^d   Chen, Shih Yin ^a   Tsai, Fuu Jen ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Genotype; Haplotype; Membranous glomerulonephritis; Single nucleotide polymorphisms; Toll like receptor 9

Indexed keywords

CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; PREDNISOLONE; TOLL LIKE RECEPTOR 9;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE COURSE; FIBROMUSCULAR DYSPLASIA; FOLLOW UP; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FIBROSIS; MAJOR CLINICAL STUDY; MEMBRANOUS GLOMERULONEPHRITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN;

ADULT; AGED; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; TAIWAN; TOLL-LIKE RECEPTOR 9;

EID: 84885940736     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.828264     Document Type: Article

References (30)

1. Schieppati A, Mosconi L, Perna A, et al. Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med. 1993;329:85-89
2. Ponticelli C. Membranous nephropathy. J Nephrol. 2007;20: 268-287
3. Murtas C, Ravani P, Ghiggeri GM. New insights into membranous glomerulo-nephritis: From bench to bedside. Nephrol Dial Transplant. 2011;26:2428-2430
4. Beck Jr. LH, Bonegio RG, Lambeau G. M-Type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11-21
5. Prunotto M, Carnevali ML, Candiano G. Autoimmunity in membranous nephron-pathy targets aldose reductase and SOD2. J Am Soc Nephrol. 2010;21:507-519
6. Bruschi M, Carnevali ML, Murtas C. Direct characterization of target podocyte antigens and autoantibodies in human membranous glomerulonephritis: Alpha-enolase and borderline antigens. J Prot. 2008;74:2008-2017
7. Couser WG, Nangaku M. Cellular and molecular biology of membranous nephron apathy. J Nephrol. 2006;19:699-705
8. Ronco P, Debiec H. New insights into the pathogenesis of membranous glomerulonephritis. Curr Opin Nephrol Hypertens. 2006;15:258-263
9. Wehrmann M, Bohle A, Bogenschutz O, et al. Long-Term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulointerstitial change. Clin Nephrol. 1989;31:67-76
10. Troyanov S, Roasio L, Pandes M, et al. Renal pathology in idiopathic membranous nephropathy: A new perspective. Kidney Int. 2006;69:1641-1648
11. Kodner C. Nephrotic syndrome in adults: Diagnosis and management. Am Fam Physician. 2009;80:1129-1134
12. Glassock RJ. Secondary membranous glomerulonephritis. Nephrol Dial Transplant. 1992;7:64-71
13. Philibert D, Cattran D. Remission of proteinuria in primary glomerulonephritis: We know the goal but do we know the price? Nat Clin Pract Nephrol. 2008;4:550-559
14. Maisonneuve P, Agodoa L, Gellert R, et al. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: Results from an international comparative study. Am J Kidney Dis. 2000;35:157-165
15. Hsu CC, Hwang SJ, Wen CP, et al. High prevalence and low awareness of CKD in Taiwan: A study on the relationship between serum creatinine and awareness from a nationally representative survey. Am J Kidney Dis. 2006;48:727-738
16. Grassmann A, Gioberge S, Moeller S, et al. ESRD patients in 2004: Global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant. 2005;20:2587-2593
17. Medzhitov R, Janeway CJ. The Toll receptor family and microbial recognition. Trends Microbiol. 2008;8:452-456
18. Diebold SS, Matoya M, Unger H, et al. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature. 2003;424:324-328
19. Blackwell SE, Krieg AM. CpG-DNA induced monocyte IFN inducible protein 10 production is regulated by plasmacytoid DC derived IFN alpha. J Immunol. 2003;170:4061-4068
20. Verthelyi D, Zeuner RA. Differential signaling by CpG DNA in DCs and B cells: Not just TLR9. Trends Immunol. 2003;24: 519-523
21. Shirali AC, Goldstein DR. Tracking the toll of kidney disease. J Am Soc Nephrol. 2008;19:1444-1450
22. Gluba A, Banach M, Hannam S, et al. The role of Toll-like receptors in renal diseases. Nat Rev Nephrol. 2010;6:224-235
23. Pawar RD, Ramanjaneyulu A, Kulkarni OP, et al. Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus. J Am Soc Nephrol. 2007;18:1721-1731
24. Papadimitraki ED, Tzardi M, Bertsias G, et al. Glomerular expression of toll-like receptor-9 in lupus nephritis but not in normal kidneys: Implications for the amplification of the inflammatory response. Lupus. 2009;18:831-835
25. Summers SA, Steinmetz OM, Ooi JD, et al. Toll-like receptor 9 enhances nephritogenic immunity and glomerular leukocyte recruitment, exacerbating experimental crescentic glomerulonephritis. Am J Pathol. 2010;177:2234-2244
26. Cattran DC. Idiopathic membranous glomerulonephritis. Kidney Int. 2001;59:1983-1994
27. Chen CH, Shu KH, Wen MC, et al. Impact of plasminogen activator inhibitor-1 gene polymorphisms on primary membranous nephropathy. Nephrol Dial Transplant. 2008;23:3166-3173
28. Bantis C, Heering PJ, Aker S, et al. Tumor necrosis factoralpha gene G-308A polymorphism is a risk factor for the development of membranous glomerulonephritis. Am J Nephrol. 2006; 26:12-15
29. Stratta P, Bermond F, Guarrera S, et al. Interaction between gene polymorphisms of nitric oxide synthase and renin-Angiotensin system in the progression of membranous glomerulonephritis. Nephrol Dial Transplant. 2004;19:587-595
30. Xu CJ, Zhang WH, Pan HF, et al. Association study of a single nucleotide polymorphism in the exon 2 region of toll-like receptor 9 (TLR9) gene with susceptibility to systemic lupus erythematosus among Chinese. Mol Biol Rep. 2009;36:2245-2248